Speaker Details

Alexandra Boer Kimball, MD, MPH, FAAD

Alexandra Boer Kimball, MD, MPH, FAAD

Harvard Medical School and Beth Israel Deaconess Medical Center

BIOGRAPHY

Dr. Kimball is CEO and President of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, an academic multi-specialty 501(c)3 physician organization with over 2400 employees, over 1 billion in revenue, and recognized by the Boston Globe as a top 10 Woman Led Business in Massachusetts. The group employs physicians and providers who practice in the Boston area, two-thirds of whom are Harvard Medical School faculty. She co-chairs the Beth Israel Lahey Health Performance Network Board (1.3 million members) and is on the Board of Trustees of Beth Israel Lahey Health. A Professor of Dermatology at Harvard Medical School, Dr. Kimball’s research focus is psoriasis and hidradenitis suppurativa. She has published over 385 papers (https://www.ncbi.nlm.nih.gov/myncbi/alexa.kimball.1/bibliography/public/), conducted over 150 clinical trials and has extensive experience in drug development and innovation, including two patents and licensing agreements. Dr. Kimball is the author of "100 Questions and Answers about Psoriasis" (available in Spanish, Greek, and Korean), "Hidradenitis Suppurativa: Your Questions, Expert Answers," and editor of "Dermatologic Diseases and Cumulative Life Course Impairment." Awards include Modern Health Care's 50 Most Influential Clinical Executives, the American Skin Association Research Award for Health Policy and Medical Education, Mentor of the Year from the Women's Dermatologic Society, the Lifetime Achievement Award from the National Psoriasis Foundation, and the Joseph B. Martin Dean's Leadership Award for the Advancement of Women Faculty at Harvard Medical School. Dr. Kimball also served on the Advisory Council to the Director of the National Institutes of Health. She has served on the Boards of the Society for Investigative Dermatology, the Massachusetts Foundation for the Humanities and Public Policy, the Hidradenitis Suppurativa Foundation, and the International Psoriasis Council. She received her MD from the Yale School of Medicine, her MPH from the Johns Hopkins Bloomberg School of Public Health, and a bachelor's degree in molecular biology and public and international affairs from Princeton University. She completed an internship in medicine at Boston's Beth Israel Hospital, her residency in dermatology at Stanford University Medical Center and a clinical research fellowship at the National Institutes of Health.

SESSIONS

S034 Late-Breaking Research: Session 2
Mar 28, 2026 1:00 PM - 4:00 PM Bellco Theatre

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Acelyrin – Investigator(Grants/Research Funding); Almirall – Board of Directors(Fees), Consultant(Honoraria); AnaptysBio – Investigator(Grants/Research Funding); Avalo Therapeutics Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); BMS – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Cellarity – Consultant (1099 relationship)(Fees); Citryll – Consultant (1099 relationship)(Fees); Curogen – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Incyte – Investigator(Grants/Research Funding); Incyte Corporation – Consultant (1099 relationship)(Fees); Innovaderm Research Inc. – Speaker(Honoraria); Insmed Incorporated – Investigator(Grants/Research Funding); Janssen Biotech – Consultant(Honoraria); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Merck – Consultant (1099 relationship)(Fees); Moonlake – Consultant(Fees), Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding); Nurix – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Investigator(Other Financial Benefit); Regeneron Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Sanofi – Consultant(Honoraria), Investigator(Fees); Sonoma Bio – Consultant(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Target RWE – Advisory Board(Fees); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding); UCSD – Advisory Board(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Fees); Ventyx Biosciences – Consultant(Fees), Consultant(Stock Options); Zura Bio – Consultant (1099 relationship)(Fees);